サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1742021

北米の外傷性脳損傷診断装置市場：2030年までの予測 - 地域別分析 - 技術別、装置別、エンドユーザー別

North America Traumatic Brain Injury Diagnostics Equipment Market Forecast to 2030 - Regional Analysis - by Techniques, Device, and End User

出版日
ページ情報
英文 204 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.42円
北米の外傷性脳損傷診断装置市場：2030年までの予測 - 地域別分析 - 技術別、装置別、エンドユーザー別
出版日: 2025年03月11日
発行: The Insight Partners
ページ情報: 英文 204 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の外傷性脳損傷診断装置市場は、2022年に13億6,002万米ドルと評価され、2030年までには33億4,017万米ドルに達すると予測され、2022年から2030年までのCAGRは11.9%と推定されます。

先進診断機器への需要加速が北米の外傷性脳損傷診断装置市場を後押し

Medical Research Council 2022の報告書によると、世界中で年間1,000万人が外傷性脳損傷（TBI）を負っています。このうち、頭部外傷で病院に入院する人の数は、男性の方が女性の1.5倍多いです。Economist Intelligence Unitの報告書によると、TBIによる世界の医療負担は年間約4,000億米ドルと推定されています。最も多いのは事故や脳卒中によるTBIです。米国疾病対策予防センター（CDC）の報告書によると、米国では年間推定170万人のTBI関連の救急外来受診、入院、死亡が発生しており、特に75歳以上の成人は歩行やバランスに問題があるため転倒のリスクが高いです。また、交通事故は米国におけるTBI関連死亡の主な原因であり、20歳から24歳の成人で最も多いです。そのため、メーカーはTBIを診断するための革新的な製品を開発しています。2023年10月、bioMerieuxは、軽度外傷性脳損傷（mTBI）患者の評価を改善することを目的とした検査である「VIDAS TBI（GFAP, UCH-L1）」の欧州適合性（CE）マーキングを発表しました。VIDAS TBI（GFAP, UCH-L1）検査は、グリア線維性酸性タンパク質（GFAP）とユビキチンC末端ヒドロラーゼL1（UCH-L1）の濃度を測定するもので、脳損傷後最初の1時間から血液中に放出される2つの脳バイオマーカーです。この検査は、受傷後12時間までの検査ウィンドウを提供する解釈の容易な検査であり、救急部での検査時間の短縮に役立ちます。

北米の外傷性脳損傷診断装置市場の概要

先進的な診断機器に対する需要の加速と、TBI患者の迅速かつ効果的な診断が市場開拓の主な原動力となっています。しかし、造影剤/媒体の副作用が市場成長の妨げとなっています。米国疾病予防管理センター（CDC）の報告によると、米国では年間250万人がTBIに苦しんでいると推定されています。KNAPP &ROBERTSの報告書によると、米国だけでも6人に1人がTBI関連の障害を抱えており、その数は約530万人にのぼります。TBIの有病率の上昇に伴い、経済的コストは765億米ドルに上ります。765億米ドルのうち、115億米ドルが直接医療費、650億米ドル近くが間接医療費です。TBIの主な原因は、転倒（45％）、自動車事故（14.3％）、暴行（10.7％）、不明（19.0％）などです。さらに、各社はTBI診断のための革新的な製品を発売しています。例えば、Abbottは2022年8月、脳損傷による転帰と治療介入を予測するための脳震盪の新しい血液検査を発表しました。調査は、脳震盪を対象とした唯一のFDA承認迅速検査であるAbbottの「i-STAT TBI Plasma Test」とAbbottのコアラボであるARCHITECT装置を用いて、脳損傷に関連する血漿中の2つのバイオマーカーを測定しました。i-STAT TBI Plasma検査は、脳損傷に反応して血流中に放出されるバイオマーカーのレベルを測定するもので、バイオマーカーのレベルはCTスキャンの必要性を判断するのに役立ちます。さらに、Sense Neuro Diagnosticsは、出血検出の臨床試験実施の許可を発表しました。FDAの神経外科、神経インターベンション、神経診断機器部門が承認した新しい臨床試験は2023年6月に開始され、米国、カナダ、インドの30施設で最大300人の患者を対象とします。この非侵襲的技術は、2.5秒以内に360のデータポイントを収集し、脳出血や脳梗塞のタイプを検出する可能性があるため、TBIを評価・監視する医師、救急部員、神経ICUチーム、軍の野戦病院による迅速な対応に役立ちます。

北米の外傷性脳損傷診断装置市場の収益と2030年までの予測（金額）

北米の外傷性脳損傷診断装置市場のセグメンテーション

北米の外傷性脳損傷診断装置市場は、技術、装置、エンドユーザー、国に分類されます。

技術別では、北米の外傷性脳損傷診断装置市場は非侵襲的手法、侵襲的手法、複合的手法に区分されます。侵襲性セグメントは2022年に北米の外傷性脳損傷診断装置市場で最大のシェアを占めました。さらに、非侵襲的セグメントは、脳波（EEG）、ブレインコンピュータインターフェース（BCI）、アイトラッキングおよび近赤外分光法（NIRS）、磁気共鳴画像法（MRI）、脳磁図（MEG）、経頭蓋磁気刺激（TMS）、脳内酸素代謝率（CMRO2）、頭蓋内圧、その他にサブ分類されます。さらに、侵襲的セグメントは、脳灌流圧（CPP）および圧反応性指数（PRx）、脳組織酸素分圧（PbtO2）、脳マイクロダイアリシス（CMD）、頭蓋内圧、その他に細分化されます。

装置別では、北米の外傷性脳損傷診断装置市場は画像診断装置とモニタリング装置に二分されます。2022年の北米の外傷性脳損傷診断装置市場は、画像診断装置分野が大きなシェアを占めています。

エンドユーザー別では、北米の外傷性脳損傷診断装置市場は病院・診療所、診断センター、その他に分けられます。2022年の北米の外傷性脳損傷診断装置市場シェアは、病院・診療所セグメントが最大でした。

国別では、北米の外傷性脳損傷診断装置市場は米国、カナダ、メキシコに区分されます。2022年の北米の外傷性脳損傷診断装置市場シェアは米国が独占しました。

GE HealthCare Technologies Inc、Elekta AB、Integra LifeSciences Holdings Corp、Natus Medical Inc、Raumedic AG、BrainScope Co Inc、Soterix Medical Inc、Medtronic Plc、Vivonics Inc、NanoDx Inc、Compumedics Ltd、Sense Diagnostics Inc、NeuraSignal Inc、Neurovigil Inc、Luciole Medical AGは、北米の外傷性脳損傷診断装置市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の外傷性脳損傷診断装置市場-主な市場力学

  • 市場促進要因
    • 先端診断機器への需要の加速
    • TBI患者の迅速かつ効果的な診断
  • 市場抑制要因
    • 造影剤/薬剤の副作用
  • 市場機会
    • 入院患者の死亡率を抑制し、診断コストをわずかに削減するため、CTよりもMRIの使用が増加中
  • 今後の動向
    • TBI患者を診断するためのポータブル非侵襲的モニタリング装置の出現
  • 促進要因と抑制要因の影響

第5章 外傷性脳損傷診断装置市場：北米市場分析

  • 北米の外傷性脳損傷診断装置市場収益、2022年～2030年
  • 入院TBI患者数
  • 価格分析

第6章 北米の外傷性脳損傷診断装置市場分析-手技別

  • 非侵襲性
  • 侵襲的手法
  • コンビネーション技法

第7章 北米の外傷性脳損傷診断装置市場の分析-デバイス別

  • 画像診断装置
  • モニタリング機器

第8章 北米の外傷性脳損傷診断装置市場の分析-エンドユーザー別

  • 病院・診療所
  • 診断センター
  • その他

第9章 北米の外傷性脳損傷診断装置市場：国別分析

    • 北米の外傷性脳損傷診断装置市場概要
    • 北米の外傷性脳損傷診断装置市場-収益と予測分析：国別
      • 米国の外傷性脳損傷診断装置市場：2030年までの収益と予測
      • カナダ：外傷性脳損傷診断装置市場：2030年までの収益と予測
      • カナダ：外傷性脳損傷診断装置市場：2030年までの収益と予測
      • メキシコ：外傷性脳損傷診断装置市場：2030年までの収益と予測
      • メキシコ：外傷性脳損傷診断装置市場：2030年までの収益と予測

第10章 業界情勢

  • 外傷性脳損傷診断装置の世界市場における成長戦略
  • 有機的開発
  • 無機的開発

第11章 企業プロファイル

  • GE HealthCare Technologies Inc
  • Elekta AB
  • Integra LifeSciences Holdings Corp
  • Natus Medical Inc
  • Raumedic AG
  • BrainScope Co Inc
  • Luciole Medical AG
  • Soterix Medical Inc
  • Medtronic Plc
  • Vivonics Inc
  • NanoDx Inc
  • Compumedics Ltd
  • Sense Diagnostics Inc
  • NeuraSignal Inc
  • Neurovigil Inc

第12章 付録

図表

List Of Tables

  • Table 1. North America Traumatic Brain Injury Diagnostics Equipment Market Segmentation
  • Table 2. United States: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Techniques
  • Table 3. United States: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-invasive
  • Table 4. United States: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-invasive ICP
  • Table 5. United States: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Invasive
  • Table 6. United States: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Invasive ICP
  • Table 7. United States: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Device
  • Table 8. United States: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 9. Canada: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Techniques
  • Table 10. Canada: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-invasive
  • Table 11. Canada: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-invasive ICP
  • Table 12. Canada: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Invasive
  • Table 13. Canada: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Invasive ICP
  • Table 14. Canada: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Device
  • Table 15. Canada: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 16. Mexico: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Techniques
  • Table 17. Mexico: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-invasive
  • Table 18. Mexico: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-invasive ICP
  • Table 19. Mexico: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Invasive
  • Table 20. Mexico: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Invasive ICP
  • Table 21. Mexico: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Device
  • Table 22. Mexico: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 23. Organic Developments Done by Companies
  • Table 24. Inorganic Developments Done by Companies
  • Table 25. Glossary of Terms, Traumatic Brain Injury Diagnostics Equipment Market

List Of Figures

  • Figure 1. North America Traumatic Brain Injury Diagnostics Equipment Market Segmentation, by Country
  • Figure 2. North America Traumatic Brain Injury Diagnostics Equipment Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Traumatic Brain Injury Diagnostics Equipment Market Revenue (US$ Million), 2022-2030
  • Figure 5. North America Traumatic Brain Injury Diagnostics Equipment Market Share (%) - by Techniques (2022 and 2030)
  • Figure 6. Non-Invasive: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Electroencephalography (EEG): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Brain-computer interface (BCI): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Eye tracking and near-infrared spectroscopy (NIRS): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Magnetic resonance imaging (MRI): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Magnetoencephalography (MEG): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Transcranial magnetic stimulation (TMS): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cerebral metabolic rate of oxygen (CMRO2): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Intracranial Pressure: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Transcranial Doppler Ultrasonography (TCD): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Tympanic Membrane Displacement (TMD): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Optic Nerve Sheath Diameter (ONSD): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Magnetic Resonance Imaging (MRI) and Computer Tomography (CT): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Fundoscopy and Papilledema: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Invasive: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Cerebral Perfusion Pressure (CPP) and Pressure Reactivity Index (PRx): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Partial Brain Tissue Oxygen Pressure (PbtO2): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Cerebral Microdialysis (CMD): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Intracranial Pressure: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. External Ventricular Drainage (EVD): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Microtransducer ICP Monitoring Devices: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Combination Techniques: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. North America Traumatic Brain Injury Diagnostics Equipment Market Share (%) - by Device (2022 and 2030)
  • Figure 31. Imaging devices: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Monitoring Devices: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Traumatic Brain Injury Diagnostics Equipment Market Share (%) - by End User (2022 and 2030)
  • Figure 34. Hospitals and Clinics: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Diagnostic Centers: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Others: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. North America Traumatic Brain Injury Diagnostics Equipment Market, by Key Countries- Revenue (2022) US$ Million
  • Figure 38. North America: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 39. United States: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 40. Canada: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 41. Mexico: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 42. Growth Strategies in the Traumatic Brain Injury Diagnostic Equipment Market
目次
Product Code: TIPRE00027272

The North America traumatic brain injury diagnostics equipment market was valued at US$ 1,360.02 million in 2022 and is expected to reach US$ 3,340.17 million by 2030; it is estimated to register a CAGR of 11.9% from 2022 to 2030.

Accelerated Demand for Advanced Diagnostic Equipment Fuels North America Traumatic Brain Injury Diagnostics Equipment Market

According to the Medical Research Council 2022 report, 10 million people across the world sustain traumatic brain injury (TBI) annually. Among these, the male population was 1.5 times higher than females admitted to hospitals for a head injury. As per The Economist Intelligence Unit report, the global healthcare burden of TBI is estimated to be around US$ 400 billion annually. The most common form of ABI is TBI due to an accident or stroke. The Centers for Disease Control and Prevention (CDC) report revealed that an estimated 1.7 million TBI-related emergency department visits, hospitalizations, and deaths occur annually in the US, especially among adults aged 75 years and older as they are at high risk of falling due to problems with gait and balance. Also, road accidents are the leading cause of TBI-related deaths in the US and are highest among adults aged 20-24 years. Therefore, manufacturers are developing innovative products to diagnose TBI. In October 2023, bioMerieux announced Conformite Europeenne (CE) marking for "VIDAS TBI (GFAP, UCH-L1)," a test intended to improve the assessment of patients suffering from mild traumatic brain injury (mTBI). VIDAS TBI (GFAP, UCH-L1) test measures the concentration of glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1)-the two brain biomarkers released into the bloodstream starting from the first hour following a brain injury. It is an easy-to-interpret test providing a test window of up to 12 hours after injury, which can help in shortening total emergency department workup time.

North America Traumatic Brain Injury Diagnostics Equipment Market Overview

The accelerated demand for advanced diagnostic equipment and quick and effective diagnosis for TBI patients are the key driving factors behind the market development. However, adverse effects of contrast/medium agent is hampering the market growth. The Centers for Disease Control and Prevention (CDC) report revealed that an estimated 2.5 million people suffer from TBI annually in the US. According to the KNAPP & ROBERTS report, 1 in every 6 Americans live with TBI-related disability in the US alone, accounting for approx. 5.3 million. With the rising prevalence of TBI, the economic cost accounts for US$ 76.5 billion. Among US$ 76.5 billion, US$ 11.5 billion accounts for direct medical costs and nearly US$ 65 billion for indirect costs. The leading causes of TBI include falls (45%), motor vehicle crashes (14.3%), assaults (10.7%), and unknown (19.0%). Further, companies are launching innovative products for the diagnosis of TBI. For instance, in August 2022, Abbott announced a new blood test for concussions to predict outcomes from brain injury and treatment interventions. The researchers used Abbott's "i-STAT TBI Plasma Test," the only FDA-cleared rapid test intended for concussion, and Abbott's core laboratory ARCHITECT instrument to measure two biomarkers in blood plasma associated with brain injury. The i-STAT TBI Plasma test measures the level of biomarkers released in the bloodstream in response to the brain injury; the level of biomarkers assist in determining the need for a CT scan. Additionally, Sense Neuro Diagnostics announced clearance to conduct clinical trials for hemorrhage detection. The new trial approved by the FDA Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices began in June 2023, including up to 300 patients at 30 US, Canada, and India sites. This noninvasive technology has a potential to collect 360 data points within 2.5 seconds to detect brain hemorrhage or stroke type, thereby helping quick response by physicians, emergency department personnels, neuro ICU teams, and military field hospitals assessing and monitoring TBI.

North America Traumatic Brain Injury Diagnostics Equipment Market Revenue and Forecast to 2030 (US$ Million)

North America Traumatic Brain Injury Diagnostics Equipment Market Segmentation

The North America traumatic brain injury diagnostics equipment market is categorized into techniques, device, end user, and country.

Based on techniques, the North America traumatic brain injury diagnostics equipment market is segmented into non-invasive, invasive, and combination techniques. The invasive segment held the largest North America traumatic brain injury diagnostics equipment market share in 2022. Furthermore, the non-invasive segment is subcategorized into electroencephalography (EEG), brain-computer interface (BCI), eye tracking and near-infrared spectroscopy (NIRS), magnetic resonance imaging (MRI), magnetoencephalography (MEG), transcranial magnetic stimulation (TMS), cerebral metabolic rate of oxygen (CMRO2), intracranial pressure, and others. Additionally, invasive segment is sub segmented into cerebral perfusion pressure (CPP) and pressure reactivity index (PRx), partial brain tissue oxygen pressure (PbtO2), cerebral microdialysis (CMD), intracranial pressure, and others.

In terms of device, the North America traumatic brain injury diagnostics equipment market is bifurcated into imaging devices and monitoring devices. The imaging devices segment held a larger North America traumatic brain injury diagnostics equipment market share in 2022.

By end user, the North America traumatic brain injury diagnostics equipment market is divided into hospitals and clinics, diagnostic centers, and others. The hospitals and clinics segment held the largest North America traumatic brain injury diagnostics equipment market share in 2022.

By country, the North America traumatic brain injury diagnostics equipment market is segmented into the US, Canada, and Mexico. The US dominated the North America traumatic brain injury diagnostics equipment market share in 2022.

GE HealthCare Technologies Inc, Elekta AB, Integra LifeSciences Holdings Corp, Natus Medical Inc, Raumedic AG, BrainScope Co Inc, Soterix Medical Inc, Medtronic Plc, Vivonics Inc, NanoDx Inc, Compumedics Ltd, Sense Diagnostics Inc, NeuraSignal Inc, Neurovigil Inc, and Luciole Medical AG, are some of the leading companies operating in the North America traumatic brain injury diagnostics equipment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Traumatic Brain Injury Diagnostics Equipment Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Accelerated Demand for Advanced Diagnostic Equipment
    • 4.1.2 Quick and Effective Diagnosis for TBI Patients
  • 4.2 Market Restraints
    • 4.2.1 Adverse Effects of Contrast Medium/Agent
  • 4.3 Market Opportunities
    • 4.3.1 Growing Use of MRI over CT to Limit Inpatient Mortality and Marginally Reduce Diagnostic Cost
  • 4.4 Future Trends
    • 4.4.1 Emergence of Portable Non-invasive Monitoring Devices to Diagnose TBI Patients
  • 4.5 Impact of Drivers and Restraints:

5. Traumatic Brain Injury Diagnostics Equipment Market - North America Market Analysis

  • 5.1 Overview
  • 5.2 North America Traumatic Brain Injury Diagnostics Equipment Market Revenue (US$ Million), 2022-2030
  • 5.3 Number of Hospitalized TBI Patients
  • 5.4 Pricing Analysis

6. North America Traumatic Brain Injury Diagnostics Equipment Market Analysis - by Techniques

  • 6.1 Overview
  • 6.2 Non-Invasive
    • 6.2.1 Overview
    • 6.2.2 Non-Invasive: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.2.3 Electroencephalography (EEG)
      • 6.2.3.1 Electroencephalography (EEG): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.2.4 Brain-computer interface (BCI)
      • 6.2.4.1 Brain-computer interface (BCI): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.2.5 Eye tracking and near-infrared spectroscopy (NIRS)
      • 6.2.5.1 Eye tracking and near-infrared spectroscopy (NIRS): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.2.6 Magnetic resonance imaging (MRI)
      • 6.2.6.1 Magnetic resonance imaging (MRI): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.2.7 Magnetoencephalography (MEG)
      • 6.2.7.1 Magnetoencephalography (MEG): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.2.8 Transcranial magnetic stimulation (TMS)
      • 6.2.8.1 Transcranial magnetic stimulation (TMS): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.2.9 Cerebral metabolic rate of oxygen (CMRO2)
      • 6.2.9.1 Overview
      • 6.2.9.2 Cerebral metabolic rate of oxygen (CMRO2): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.2.10 Intracranial Pressure
      • 6.2.10.1 Overview
      • 6.2.10.2 Intracranial Pressure: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.2.10.3 Transcranial Doppler Ultrasonography (TCD)
        • 6.2.10.3.1 Transcranial Doppler Ultrasonography (TCD): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.2.10.4 Tympanic Membrane Displacement (TMD)
        • 6.2.10.4.1 Tympanic Membrane Displacement (TMD): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.2.10.5 Optic Nerve Sheath Diameter (ONSD)
        • 6.2.10.5.1 Optic Nerve Sheath Diameter (ONSD): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.2.10.6 Magnetic Resonance Imaging (MRI) and Computer Tomography (CT)
        • 6.2.10.6.1 Magnetic Resonance Imaging (MRI) and Computer Tomography (CT): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.2.10.7 Fundoscopy and Papilledema
        • 6.2.10.7.1 Fundoscopy and Papilledema: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.2.11 Others
      • 6.2.11.1 Others: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Invasive
    • 6.3.1 Overview
    • 6.3.2 Invasive: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.3.3 Cerebral Perfusion Pressure (CPP) and Pressure Reactivity Index (PRx)
      • 6.3.3.1 Cerebral Perfusion Pressure (CPP) and Pressure Reactivity Index (PRx): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.3.4 Partial Brain Tissue Oxygen Pressure (PbtO2)
      • 6.3.4.1 Partial Brain Tissue Oxygen Pressure (PbtO2): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.3.5 Cerebral Microdialysis (CMD)
      • 6.3.5.1 Cerebral Microdialysis (CMD): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.3.6 Intracranial Pressure
      • 6.3.6.1 Overview
      • 6.3.6.2 Intracranial Pressure: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.6.3 External Ventricular Drainage (EVD)
        • 6.3.6.3.1 External Ventricular Drainage (EVD): Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.6.4 Microtransducer ICP Monitoring Devices
        • 6.3.6.4.1 Microtransducer ICP Monitoring Devices: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.3.7 Others
      • 6.3.7.1 Others: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Combination Techniques
    • 6.4.1 Overview
    • 6.4.2 Combination Techniques: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Traumatic Brain Injury Diagnostics Equipment Market Analysis - by Device

  • 7.1 Overview
  • 7.2 Imaging devices
    • 7.2.1 Overview
    • 7.2.2 Imaging devices: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Monitoring Devices
    • 7.3.1 Overview
    • 7.3.2 Monitoring Devices: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Traumatic Brain Injury Diagnostics Equipment Market Analysis - by End User

  • 8.1 Overview
  • 8.2 Hospitals and Clinics
    • 8.2.1 Overview
    • 8.2.2 Hospitals and Clinics: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Diagnostic Centers
    • 8.3.1 Overview
    • 8.3.2 Diagnostic Centers: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Traumatic Brain Injury Diagnostics Equipment Market - Country Analysis

    • 9.1.1 North America Traumatic Brain injury Diagnostic Equipment Market Overview
    • 9.1.2 North America: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast Analysis - by Country
      • 9.1.2.1 United States: Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.1.1 United States: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Techniques
        • 9.1.2.1.2 United States: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Non-invasive
          • 9.1.2.1.2.1 United States: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Non-invasive ICP
        • 9.1.2.1.3 United States: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Invasive
          • 9.1.2.1.3.1 United States: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Invasive ICP
        • 9.1.2.1.4 United States: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Device
        • 9.1.2.1.5 United States: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by End User
      • 9.1.2.2 Canada: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.2.1 Overview
      • 9.1.2.3 Canada: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.3.1 Canada: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Techniques
        • 9.1.2.3.2 Canada: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Non-invasive
          • 9.1.2.3.2.1 Canada: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Non-invasive ICP
        • 9.1.2.3.3 Canada: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Invasive
          • 9.1.2.3.3.1 Canada: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Invasive ICP
        • 9.1.2.3.4 Canada: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Device
        • 9.1.2.3.5 Canada: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by End User
      • 9.1.2.4 Mexico: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.4.1 Overview
      • 9.1.2.5 Mexico: Traumatic Brain Injury Diagnostics Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.5.1 Mexico: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Techniques
        • 9.1.2.5.2 Mexico: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Non-invasive
          • 9.1.2.5.2.1 Mexico: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Non-invasive ICP
        • 9.1.2.5.3 Mexico: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Invasive
          • 9.1.2.5.3.1 Mexico: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Invasive ICP
        • 9.1.2.5.4 Mexico: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by Device
        • 9.1.2.5.5 Mexico: Traumatic Brain Injury Diagnostics Equipment Market Breakdown, by End User

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Global Traumatic Brain Injury Diagnostic Equipment Market
  • 10.3 Organic Developments
    • 10.3.1 Overview
  • 10.4 Inorganic Developments
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 GE HealthCare Technologies Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Elekta AB
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Integra LifeSciences Holdings Corp
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Natus Medical Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Raumedic AG
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 BrainScope Co Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Luciole Medical AG
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Soterix Medical Inc
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Medtronic Plc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Vivonics Inc
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 NanoDx Inc
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments
  • 11.12 Compumedics Ltd
    • 11.12.1 Key Facts
    • 11.12.2 Business Description
    • 11.12.3 Products and Services
    • 11.12.4 Financial Overview
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Developments
  • 11.13 Sense Diagnostics Inc
    • 11.13.1 Key Facts
    • 11.13.2 Business Description
    • 11.13.3 Products and Services
    • 11.13.4 Financial Overview
    • 11.13.5 SWOT Analysis
    • 11.13.6 Key Developments
  • 11.14 NeuraSignal Inc
    • 11.14.1 Key Facts
    • 11.14.2 Business Description
    • 11.14.3 Products and Services
    • 11.14.4 Financial Overview
    • 11.14.5 SWOT Analysis
    • 11.14.6 Key Developments
  • 11.15 Neurovigil Inc
    • 11.15.1 Key Facts
    • 11.15.2 Business Description
    • 11.15.3 Products and Services
    • 11.15.4 Financial Overview
    • 11.15.5 SWOT Analysis
    • 11.15.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms